CTSO - MCAP CO - Cytosorbents

Cytosorbents (CTSO) is highly valued by European physicians for the effectiveness of its developments and is actively gaining trust in the US. This chart reflects the current share price on the GURU.Markets platform at 0.01. The business generates revenue by creating unique filters for toxin removal during sepsis, possessing significant pricing power. Additionally, Cytosorbents (CTSO) is implementing eco-friendly production standards, reducing plastic waste and optimizing sterilization.

Market capitalization reflects the total business value through the lens of current quotes. This indicator is calculated by multiplying the price of a single share by the total number of issued securities. By analyzing the market value of all issued shares, an investor determines trend phases and asset overbought risks. For Cytosorbents (CTSO), the dynamics of this metric confirm market confidence in its innovations. The diversification of blood purification system applications across various medical fields stabilizes the business valuation.